Company / Depreciation & Amortization
Aurinia Pharmaceuticals Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$19.4M
FY2025
5-year range
$33.0K / $19.4M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#47 of 163
Health Care
What the data says
At $19M, Aurinia Pharmaceuticals Inc.'s depreciation & amortization ranks #117 of 163 in the Health Care sector. Depreciation & Amortization has increased for 4 consecutive years, from $33,000 in FY2021 to $19M in FY2025.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of +70.0%.
Increased from $12M to $19M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +142.1%
- 5-Year CAGR
- +70.0%
- 10-Year CAGR
- -
Sector benchmark
#117 of 163 in Health CareTop 71% of 163This company $19.4M Sector average $219.4M
▼
-91.1% below sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +70.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 0.0% year-over-year.
- Ranks #47 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.4M | +0.0% |
| FY2024 | $19.4M | +67.0% |
| FY2023 | $11.6M | +749.5% |
| FY2022 | $1.4M | +4054.5% |
| FY2021 | $33.0K | -97.6% |
| FY2020 | $1.4M | +4054.5% |
| FY2019 | $33.0K | +65.0% |
| FY2018 | $20.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026